Advarra, a clinical research tech firm based in Maryland, has introduced a new digital solution aimed at speeding up study startups and improving collaboration between trial sponsors and research sites. The solution combines Advarra’s study startup delivery program with single sign-on capabilities. The new offering features two main products: Advarra Study Startup and Advarra Enroll.
These tools are designed to guide researchers through the processes of activating sites and planning and tracking patient enrollment. Trial sponsors or CROs provide the study service to research sites to assist with tasks such as feasibility assessments, document exchange, site training, milestone tracking, and enrollment planning. Advarra’s platform allows both sponsors and sites to view the entire study startup workflow using their own credentials, reducing administrative burdens.
Study startup remains one of the most challenging aspects of clinical trials, and it takes time to progress through every milestone—from site identification and feasibility to ethics reviews, contract negotiations, and site training,” said Ashley Davidson, vice president at Advarra.
Advarra’s new streamlined solution debuts
“By automating workflows and integrating site activation processes such as regulatory submissions, document management, and training, we’re reducing redundancies and saving valuable time.”
The solution includes two products that work together to guide study teams through the site activation process and enhance enrollment planning and tracking.
This development is supported by a multi-year technology investment aimed at speeding up site activation and ensuring compliance. Davidson added, “Our Study Collaboration solution builds on our role as a trusted partner to over 50,000 monthly research site users of our clinical trial management technology across more than 17,000 facilities. These enhancements strengthen collaboration between stakeholders, improve compliance, and accelerate research timelines, ultimately helping to bring new treatments to patients faster.”
Study Collaboration provides a centralized, real-time view of activation and enrollment progress across all sites.
This solution allows sites and sponsor study teams to access the entire startup workflow using their own credentials, reducing administrative burden and improving engagement. Parexel continuously enhances our collaboration with investigative sites to accelerate study startup timelines and reduce burdens on their staff,” said Ronald Mevoungou, Parexel’s President of Global Clinical and Data Operations. “Advarra’s technology has been crucial in consolidating multiple site tasks into one streamlined integrated system—including study training, document exchange, communication, and visit guidance—providing sites with access via ‘Advarra One’ single sign-on, which has been widely adopted by the clinical research community.”
Nancy Cleverley, Senior Vice President of Operations Management at the Alliance for Multispecialty Research (AMR), also praised Study Collaboration: “The interoperability of Advarra’s technologies simplifies our study startup workflows, which is especially important for industry trials that require extensive coordination with sponsors and CROs.
By removing redundancies in study startup activities, we save time and shorten our activation timelines.”
In related news, Fortrea, Veeva, and Advarra have entered into a pact to streamline clinical trials, furthering the goal of efficient and effective research operations.
